Changchun GeneScience Pharmaceutical Co., Ltd.
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- -
- Established
- 1948-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://english.ciac.cas.cn/
Phase III Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children
Phase 3
Completed
- Conditions
- First Posted Date
- 2011-12-20
- Last Posted Date
- 2017-07-31
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 343
- Registration Number
- NCT01495468
Efficiency and Safety Study of Pegylated Somatropin to Treat Growth Hormone Deficiency Children
Phase 2
Completed
- Conditions
- First Posted Date
- 2011-04-27
- Last Posted Date
- 2017-07-31
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 101
- Registration Number
- NCT01342146
© Copyright 2024. All Rights Reserved by MedPath